Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Solid Biosciences
Biotech
Solid soars as early DMD gene therapy data beat expectations
The biotech reported expectation-busting phase 1 data on its next-generation candidate, sending its stock spiraling upward.
Nick Paul Taylor
Feb 18, 2025 8:10am
DOJ accuses billionaire of insider trading in Solid Bio, Mirati
Jul 26, 2023 9:34am
Solid Bio hopes to fortify itself after absorbing AavantiBio
Sep 30, 2022 10:30am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
Pfizer, Sarepta team with DMD gene therapy makers for analysis
May 17, 2022 3:39pm
Moderna plucks Merck marketing head for CCO job—Chutes & Ladders
Apr 29, 2022 9:00am
